JAMP SODIUM POLYSTYRENE SULFONATE
JAMP PHARMA CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of JAMP SODIUM POLYSTYRENE SULFONATE in Canada?
Yes. JAMP SODIUM POLYSTYRENE SULFONATE 1G has an active shortage reported to Health Canada (last updated September 21, 2026).
Why is JAMP SODIUM POLYSTYRENE SULFONATE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will JAMP SODIUM POLYSTYRENE SULFONATE be available again?
The manufacturer's estimated resolution date is December 25, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
KAYEXALATE
SANOFI-AVENTIS CANADA INC
PMS-SODIUM POLYSTYRENE SULFONATE
PHARMASCIENCE INC
Other Products
SPS SUSPENSION 15GM/60ML
CAROLINA MEDICAL PRODUCTS COMPANY
SOLYSTAT
PENDOPHARM DIVISION OF PHARMASCIENCE INC
K-EXIT POUDRE
OMEGA LABORATORIES LIMITED
PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA
PHARMEL INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-25
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02497557
Strength
1G
Dosage Form
POWDER FOR SUSPENSION
Route
RECTAL ORAL
Active Ingredient
SODIUM POLYSTYRENE SULFONATE
Tier
Unrated
Last Updated
2026-09-21
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164